This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chilosi, M. Articles by Semenzato, G. Search for Related Content PubMed PubMed Citation Articles by Chilosi, M. Articles by Semenzato, G.

American Journal of Pathology, Vol 143, 1348-1355, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues

M Chilosi, M Lestani, A Benedetti, L Montagna, S Pedron, A Scarpa, F Menestrina, S Hirohashi, G Pizzolo and G Semenzato
Instituto di Anatomia Pathologica, Universita di Verona, Italy.

Tenascin is a major extracellular matrix glycoprotein that can interfere with the action of fibronectin by inhibiting cell adhesion and spreading. Although tenascin is able to exert important immunomodulatory activities on T and B cells and macrophages, little is known about its distribution in different lymphohemopoietic tissues. In this study we have analyzed tenascin immunoreactivity on cryostat and paraffin sections of normal and pathological lymphoid tissues using two different monoclonal antibodies. We demonstrated strong tenascin expression in all peripheral lymphoid tissues, whereas it was barely detectable in the thymus and in bone marrow. In reactive lymph nodes, tenascin was mainly found in T-dependent zones, forming a variably close-woven reticular network corresponding to fibroblastic reticulum cells and blood vessels basal laminae, showing a partial co- localization with fibronectin. In B-dependent zones, tenascin was restricted to blood vessels. Using double-marker analysis, we performed a thorough study comparing tenascin expression in different compartments of lymphoid microenvironments. Tenascin network appeared much thicker in chronically stimulated tissues, where CD4+ lymphocytes with "memory" phenotype (CD45RO+/CD45RA-) were predominant, and at sites of ongoing inflammation. In particular, a striking increase of tenascin was observed in sarcoid lymph node, as well as in myasthenic hyperplastic thymuses. In addition, tenascin can be abnormally synthesized in tissue involved by various types of lymphomas, including Hodgkin's disease and hairy cell leukemia.

This article has been cited by other articles:

				M. D. Puente Navazo, D. Valmori, and C. Ruegg The Alternatively Spliced Domain TnFnIII A1A2 of the Extracellular Matrix Protein Tenascin-C Suppresses Activation-Induced T Lymphocyte Proliferation and Cytokine Production J. Immunol., December 1, 2001; 167(11): 6431 - 6440. [Abstract] [Full Text] [PDF]

				J. D. Loike, L. Cao, S. Budhu, S. Hoffman, and S. C. Silverstein Blockade of {{alpha}}5{{beta}}1 Integrins Reverses the Inhibitory Effect of Tenascin on Chemotaxis of Human Monocytes and Polymorphonuclear Leukocytes Through Three-Dimensional Gels of Extracellular Matrix Proteins J. Immunol., June 15, 2001; 166(12): 7534 - 7542. [Abstract] [Full Text] [PDF]

				M. Gonzalez, F. Mackay, J. L. Browning, M. H. Kosco-Vilbois, and R. J. Noelle The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles J. Exp. Med., April 6, 1998; 187(7): 997 - 1007. [Abstract] [Full Text] [PDF]

				R. A. Clark, H. P. Erickson, and T. A. Springer Tenascin Supports Lymphocyte Rolling J. Cell Biol., May 5, 1997; 137(3): 755 - 765. [Abstract] [Full Text] [PDF]